spermine has been researched along with natriuretic peptide, c-type in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hobbs, AJ; MacAllister, RJ; Madhani, M; Scotland, RS | 1 |
| Baldini, PM; Beninati, S; De Vito, P; Lentini, A; Mattioli, P; Provenzano, B; Vismara, D | 1 |
| Ahluwalia, A; Hobbs, AJ; Kemp-Harper, B; Madhani, M; Nobles, M; Panayiotou, CM; Scotland, RS; Sheraz, A; Villar, IC | 1 |
3 other study(ies) available for spermine and natriuretic peptide, c-type
| Article | Year |
|---|---|
Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Cyclic GMP; Dose-Response Relationship, Drug; Drug Antagonism; Drug Synergism; Guanylate Cyclase; Male; Mesenteric Arteries; Mice; Mice, Inbred Strains; Mice, Knockout; Muscle Relaxation; Natriuretic Peptide, C-Type; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitrogen Oxides; Nitroglycerin; Oxadiazoles; Phenylephrine; Polysaccharides; Quinoxalines; Receptors, Atrial Natriuretic Factor; Signal Transduction; Spermine | 2003 |
Decrease of polyamine levels and enhancement of transglutaminase activity in selective reduction of B16-F10 melanoma cell proliferation induced by atrial natriuretic peptide.
Topics: Animals; Aorta; Atrial Natriuretic Factor; Cell Line, Tumor; Cell Proliferation; Epidermal Growth Factor; Humans; Male; Melanins; Melanoma, Experimental; Muscle, Smooth, Vascular; Natriuretic Agents; Natriuretic Peptide, C-Type; Polyamines; Putrescine; Rats; Rats, Wistar; Spermidine; Spermine; Transglutaminases | 2006 |
Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor.
Topics: Acetylcholine; Animals; Aorta; Atrial Natriuretic Factor; Barium; Biological Factors; In Vitro Techniques; Male; Membrane Potentials; Mesenteric Arteries; Natriuretic Peptide, C-Type; Oligopeptides; Ouabain; Patch-Clamp Techniques; Potassium Channels; Pyrazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor; Reverse Transcriptase Polymerase Chain Reaction; Sodium-Potassium-Exchanging ATPase; Spermine; Vasodilation; Vasodilator Agents | 2007 |